当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析 - 现金流量表

冠昊生物

(300238)

  

流通市值:41.63亿  总市值:41.63亿
流通股本:2.65亿   总股本:2.65亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金327,735,041.46213,008,492.08101,644,327.74405,600,477.34
  收到的税费返还---1,075,517
  收到其他与经营活动有关的现金9,845,710.897,810,201.456,246,407.523,947,764.04
  经营活动现金流入小计337,580,752.35220,818,693.53107,890,735.24430,623,758.38
  购买商品、接受劳务支付的现金52,078,873.1432,258,121.1117,166,330.3977,269,175.98
  支付给职工以及为职工支付的现金84,693,045.1254,933,456.8333,739,974.43105,614,558.26
  支付的各项税费33,297,221.8523,927,704.187,383,196.7939,843,932.35
  支付其他与经营活动有关的现金114,875,772.0770,420,283.1634,530,475.83158,341,294.8
  经营活动现金流出小计284,944,912.18181,539,565.2892,819,977.44381,068,961.39
  经营活动产生的现金流量净额52,635,840.1739,279,128.2515,070,757.849,554,796.99
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额27,914.3527,914.3524,119.3598,550
  投资活动现金流入小计27,914.3527,914.3524,119.3598,550
  购建固定资产、无形资产和其他长期资产支付的现金29,590,534.7524,535,775.0824,035,408.2576,203,040.19
  投资支付的现金---5,281,026.87
  取得子公司及其他营业单位支付的现金300,000898,382.18-3,563,536.9
  支付其他与投资活动有关的现金898,382.18-898,382.18-
  投资活动现金流出小计30,788,916.9325,434,157.2624,933,790.4385,047,603.96
  投资活动产生的现金流量净额-30,761,002.58-25,406,242.91-24,909,671.08-84,949,053.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,101,3006,101,3006,101,300-
  其中:子公司吸收少数股东投资收到的现金6,101,300-6,101,300-
  取得借款收到的现金35,950,00024,000,00024,000,00085,000,000
  筹资活动现金流入小计42,051,30030,101,30030,101,30085,000,000
  偿还债务支付的现金20,000,0002,000,0001,000,00030,800,000
  分配股利、利润或偿付利息支付的现金2,815,202.781,941,819.45998,643.072,464,230.59
  支付其他与筹资活动有关的现金4,056,317.983,451,605.57867,268.628,141,238.84
  筹资活动现金流出小计26,871,520.767,393,425.022,865,911.6941,405,469.43
  筹资活动产生的现金流量净额15,179,779.2422,707,874.9827,235,388.3143,594,530.57
四、汇率变动对现金及现金等价物的影响-103,782.15-113,482.72-25,515.77175,121.04
五、现金及现金等价物净增加额36,950,834.6836,467,277.617,370,959.268,375,394.64
  加:期初现金及现金等价物余额104,483,800.11104,483,800.11104,483,800.1196,108,405.47
  期末现金及现金等价物余额141,434,634.79140,951,077.71121,854,759.37104,483,800.11
补充资料:
  净利润-16,512,890.17-16,607,493.45
  资产减值准备-1,736,227.74-24,515,652.84
  固定资产和投资性房地产折旧-6,267,314.08-10,822,046.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-6,267,314.08-10,822,046.1
  无形资产摊销-4,013,956.34-9,768,134.67
  长期待摊费用摊销-503,609.34-1,010,423.93
  处置固定资产、无形资产和其他长期资产的损失-5,569.63--32,334.57
  固定资产报废损失-12,808.87-55,102.05
  财务费用-2,167,804.25-1,718,844.26
  投资损失--143,125--606,241.58
  递延所得税--352,617.19--1,578,677.87
  其中:递延所得税资产减少-221,555.25--3,454,659.62
    递延所得税负债增加--574,172.44-1,875,981.75
  存货的减少-4,468,165.58--2,127,962.49
  经营性应收项目的减少-411,121.83-19,959,200.26
  经营性应付项目的增加-1,254,118.81--36,825,880.67
  现金的期末余额-140,951,077.71-104,483,800.11
  减:现金的期初余额-104,483,800.11-96,108,405.47
  现金及现金等价物的净增加额-36,467,277.6-8,375,394.64
公告日期2025-10-292025-08-282025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑